Copy Link Print Information

Dilpacimab

(別名: ABT165; PR1283233)
カスタマーレビュー

Based on 1 Customer Validation

Dilpacimab (ABT165) is a bispecific variable domain immunoglobulin. Dilpacimab binds to and inhibits DLL4 and VEGF and acts as a tumor growth inhibitor. Dilpacimab can be used in research related to metastatic colorectal cancer and advanced solid tumors.

商品は「研究用試薬」です。人や動物の医療用・臨床診断用・食品用の製品ではありません。
研究用途以外に使用した場合、当社は一切の責任を負いかねます。

  • 純度: 96.88%
  • CAS 番号: 1791420-09-1
  • 分子量:199.12 kDa
  • 保管条件:

    Please store the product under the recommended conditions in the Certificate of Analysis.

  • Experimental Validation Results for Dilpacimab
  • Experimental Validation Results for Dilpacimab
  • Experimental Validation Results for Dilpacimab
  • Dilpacimab Chemical Structure
    Dilpacimab 構造式
CAS 番号: 1791420-09-1
容量
価格（税別）
在庫状況
数量
Amount: USD 0.00
Please select quantity
or
or

* アイテムを追加する前、数量をご選択ください

To place orders, for customer services and technical support, please contact: MedChemExpress USA

Tel: 609-228-6898 E-mail: [email protected] [email protected]

Data Download
Dilpacimab おすすめ製品:

To place orders, for customer services and technical support, please contact:

609-228-6898
[email protected] [email protected]
最寄りの代理店をお探しください Your local distributor: Hycultec GmbHHycultec
  • 生物活性
  • 化学情報
  • 純度とドキュメンテーション
  • 参考文献
  • Help & FAQs
You May Still Need
Top Publications Citing

Use of MCE Products

VEGFR アイソフォーム固有の製品をすべて表示

More
Keywords
MOQ
Minimum order quantity
100 mg

お問い合わせ 在庫あり

Other size
お問い合わせ
Please select quantity
Amount: USD 0.00
Sign in to MedChemExpress ログイン
Register
Sign in to MedChemExpress
新規会員登録

At least 6 characters

Personalize your experience, you are currently not signed in. For a better experience, please create an online profile, you can:

Obtain points redemption prizes
Check out faster
Add multiple shipping locations
View orders
Assay Types
  • 1/16

    [VH-VH'-H-Gamma1_VL-VL'-C-kappa]-dimer

  • 1/16

    Immobilized Delta-like protein 4/DLL4 Protein, Human can bind Dilpacimab. The EC50 for this effect is 5.82 ng/mL.

  • 1/16

    Flow cytometric analysis of 1X106 HeLa cells with Dilpacimab (HY-P99852, red). Cells were fixed with 4% paraformaldehyde. Then stained with the primary antibody at 1/200 dilution for an hour at 4℃. AF 488-conjugated AffiniPure Goat Anti-Human IgG H&L (HY-P83776) was used as the secondary antibody at 1/1,000 dilution for 30 minutes at 4℃. Human IgG1 kappa (HY-P99001, blue) was used as the isotype control.

  • Dilpacimab Chemical Structure
    1/16
  • Dilpacimab
  • Immobilized Delta-like protein 4/DLL4 Protein, Human can bind Dilpacimab. The EC50 for this effect is 5.82 ng/mL.
  • Flow cytometric analysis of 1X106 HeLa cells with Dilpacimab (HY-P99852, red). Cells were fixed with 4% paraformaldehyde. Then stained with the primary antibody at 1/200 dilution for an hour at 4℃. AF 488-conjugated AffiniPure Goat Anti-Human IgG H&L (HY-P83776) was used as the secondary antibody at 1/1,000 dilution for 30 minutes at 4℃. Human IgG1 kappa (HY-P99001, blue) was used as the isotype control.
  • [VH-VH'-H-Gamma1_VL-VL'-C-kappa]-dimer